| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDT | Ordinary Shares | Award | $0 | +14,375 | +48.76% | $0 | 43,858 | 29 Jul 2024 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDT | Performance Share Unit | Award | $0 | +35,938 | $0 | 35,938 | 29 Jul 2024 | Performance Share Units | 35,938 | Direct | F3, F4, F5 | ||
| transaction | MDT | Stock Option (Right to Buy) | Award | $0 | +106,260 | $0 | 106,260 | 29 Jul 2024 | Ordinary Shares | 106,260 | $80 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. |
| F2 | Includes 573 shares acquired through dividend reinvestment since the last report filed by the reporting person. |
| F3 | Each performance share unit represented a contingent right to receive one share of Medtronic common stock. |
| F4 | Vests on July 29, 2027. |
| F5 | The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 35,983 shares will be issued. If maximum performance metrics are achieved, 71,876 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. |
| F6 | These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |